| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4345115 | Neuroscience Letters | 2011 | 4 Pages |
Abstract
⺠Tamoxifen, a PKC inhibitor and antiestrogenic drug, blocked methylphenidate-induced hyperlocomotion. ⺠Medroxyprogesterone and clomiphene, antiestrogenic drugs, did not block methylphenidate-induced hyperlocomotion. ⺠These results indicated that the antimanic-like effect of tamoxifen is related to its PKC activity.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Marcela Pereira, Bruno Jacson Martynhak, Irinéia Paulina Baretta, Diego Correia, Isadora Pozzetti Siba, Roberto Andreatini,